Biblio Discovery — Demo Discovery Service

63 results

Showing 1–20 · 2.00 seconds · RSS

Journal

European Medical Journal Hematology (2022)

ISSN 2053-6631 · European Medical Journal · 63 articles in the index

  1. Journal Article

    IMRT/IGRT Helical Tomotherapy: A Successful Treatment of Lung Parenchyma Compression Due to Extramedullary Haematopoiesis in Β-thalassaemia – a Case Report

    Giorgia De Gregorio; Salvatore D’Alessandro; Giovanna Trapani et al.

    European Medical Journal Hematology (2022) · 2022 · English · DOAJ

    Thalassaemia is a chronic haemolytic anaemia that is endemic in the Mediterranean Basin. Extramedullary haematopoiesis (EMH) is a natural compensatory reaction involving several organs or tissues. This report outlines a case of dyspnoea due to bilateral dorsal paravertebral EMH, which was treated…

  2. Journal Article

    Social Impact and Quality of Life of Patients with β-Thalassaemia: A Systematic Review

    Francesca Greco; Franca Marino

    European Medical Journal Hematology (2022) · 2022 · English · DOAJ

    β-Thalassaemia (BT) is a hereditary genetic blood disease caused by a mutation in the gene that encodes the haemoglobin protein. In the most severe forms, BT forces patients to undergo frequent blood transfusions, which has a significant impact on the quality of life. Classified as rare, BT is very…

  3. Journal Article

    Von Willebrand Disease-Associated Angiodysplasia: Presentation of a Paediatric Case

    Samira Aggoune; Nacer Djidjli; Hachemi Maouche

    European Medical Journal Hematology, Pp 53-57 (2022) · 2022 · English · DOAJ

    Von Willebrand disease (VWD) is a bleeding disorder, resulting from a quantitative or qualitative defect in von Willebrand factor (VWF). A regulatory role for VWF in angiogenesis was postulated upon the clinical observation that qualitative or quantitative VWF defects are associated with the…

  4. Journal Article

    Atorvastan, Apsirin and Hydorxyurea for an Effective and Low-Cost Treatment in High-Risk Polycythemia Vera

    Ricardo Amaru; Mireya Carrasco; Victor R Gordeuk et al.

    European Medical Journal Hematology (2022) · 2022 · English · DOAJ

    Introduction: Polycythemia vera (PV) treatment focuses on preventing thrombotic events and delaying transformation to myelofibrosis or leukaemia. According to risk stratification, low-risk patients require therapeutic phlebotomy combined with acetylsalicylic acid, whilst the treatment of high-risk…

  5. Journal Article

    Digital Necrosis as Initial Manifestation of Multiple Myeloma: An Unusual Case Report

    Hind Zrikem; Abderrahim Raissi; Salma Amrani Idrissi et al.

    European Medical Journal Hematology (2022) · 2022 · English · DOAJ

    Clinical manifestations of multiple myeloma are variable. The authors report a 68-year-old female who presented to the hospital with bilateral digital necrosis and dry gangrenous toes in both left and right feet. She was diagnosed with IgA-λ multiple myeloma associated with Type I…

  6. Journal Article

    Gastrointestinal Manifestations and Liver Injury: Correlation with Mortality and Clinical Outcomes in Patients with COVID-19

    Michael Makar; Carlos D. Minacapelli; Kapil Gupta et al.

    European Medical Journal Hematology, Vol. 9 No. 1 · 2021 · English · DOAJ

    Background and aims: Reports indicate that patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection present with gastrointestinal (GI) manifestations and abnormal liver function; however, the impact on clinical findings is unclear. The aim of this study is to report the…

  7. Journal Article

    Isatuximab and Belantamab Mafodotin: A Primer to an Evolving Multiple Myeloma Landscape

    Rebecca Gonzalez; Hanna Bailey; Omar Castaneda Puglianini

    European Medical Journal Hematology (2021) · 2021 · English · DOAJ

    Multiple myeloma (MM) continues to be an incurable disease impacting mainly an ageing population. Comorbidities, disease characteristics, and drug toxicity profiles heavily influence treatment selections. Despite single agent activity of many anti-MM agents, opportunities to maintain responses most…

  8. Journal Article

    Glanzmann Thrombasthenia: A Case Report of a Rare Inherited Coagulation Disorder Presenting with Traumatic Head Injury

    Vishal Chakati; Durga Prasad Bukka; Srinivas Rao Erigaisi et al.

    European Medical Journal Hematology, Pp 110-113 (2021) · 2021 · English · DOAJ

    This case study deals with a 32-year-old Indian male patient who presented with a traumatic head injury in the hospital, experienced uncontrolled bleeding after conducting surgery, and was eventually diagnosed with Glanzmann thrombasthenia. Glanzmann thrombasthenia is a rare hereditary blood…

  9. Journal Article

    Management of Multiple Myeloma in Older Patients

    Jian Li; Henry Chan

    European Medical Journal Hematology, Pp 69-81 (2021) · 2021 · English · DOAJ

    Multiple myeloma is a condition that affects predominantly the older population. There are now various approved chemotherapy regimens as a result of advances in treatment. Choosing the optimal regimen for older patients with myeloma remains a challenge because of frailty and a lack of head-to-head…

  10. Journal Article

    Recurrent Episodes of Angioedema as Presenting Feature of JAK2-Positive Myeloproliferative Disorder Consistent with Polycythaemia Vera

    Laith Al-Azrai; Ala’a Abdullah Bani Mustafa; Adi Yousef al-Wahadneh

    European Medical Journal Hematology, Pp 105-109 (2021) · 2021 · English · DOAJ

    Polycythaemia vera (PV) is one of the chronic myeloproliferative neoplasms, which are collectively characterised by clonal proliferation of myeloid cells with variable morphologic maturity and haematopoietic efficiency. PV is distinguished clinically from other myeloproliferative neoplasms by the…

  11. Journal Article

    Current and Future Therapies for β-Thalassaemia: A Review Article

    Livia Giannoni; Emanuele Angelucci

    European Medical Journal Hematology, Pp 94-104 (2021) · 2021 · English · DOAJ

    This article will review recent and forthcoming advances in the treatment of thalassaemia. Prognosis of thalassaemia has dramatically improved in the last 50 years with the development of regular and safe blood transfusions and iron chelation. Almost 20 years ago, development of oral chelators, and…

  12. Journal Article

    Concerns Regarding the Management of β-Thalassaemia Patients in the Era of COVID-19

    Constantina Aggeli; Sophia Delicou; Dimitrios Patsourakos et al.

    European Medical Journal Hematology, Vol. 8 No. 1 · 2020 · English · DOAJ

    Many cases of pneumonia clustered in the city of Wuhan, China, were reported in December 2019, and source tracing has showed Huanan Seafood Market, Wuhan, China, as the origin. In this work, the authors summarise their concerns for thalassaemia patients, a unique group with several heart, liver…

  13. Journal Article

    Initial Anticoagulant Management of Deep Vein Thrombosis/Venous Thromboembolism in Primary Care: Review of Current Approaches

    Pablo Millares Martin

    European Medical Journal Hematology, Vol. 8 No. 1 · 2020 · English · DOAJ

    Background and Aims: The initial management of deep vein thrombosis is starting to happen in general practice. New treatments are available to allow this shift, but guidance is variable. The aim of this study was to understand current choices used in general practice in the UK and to determine if…

  14. Journal Article

    Pregnancy-Related Thromboembolism in Sickle Cell Disease

    Salma M. AlDallal

    European Medical Journal Hematology, Vol. 8 No. 1 · 2020 · English · DOAJ

    Haematological disorders are predominant in the tropical and subtropical countries where major problems of sickle-cell disease (SCD) and thalassaemias are often recorded. However, reports of these conditions have increased in the Western hemisphere more recently. Genetic counselling, early…

  15. Journal Article

    Adult-Onset Still’s Disease Complicated with Haemophagocytic Lymphohistiocytosis (HLH): A Case Report

    Muhammad Sohaib Asghar; Abubakar Tauseef; Warda Fatmi et al.

    European Medical Journal Hematology, Vol. 8 No. 1 · 2020 · English · DOAJ

    Haemophagocytic lymphohistiocytosis (HLH) is a rare but potentially aggressive and life-threatening syndrome of overactive histiocytes and lymphocytes that commonly affects infants; it is also observed in children and adults of all ages. The disease is differentiated into either primary or…

  16. Journal Article

    Expanding the Role of CAR-T Cell Therapy to Systemic Lupus Erythematosus

    Shreya Patel; Kelly Brassil; Paiboon Jungsuwadee

    European Medical Journal Hematology, Vol. 8 No. 1 · 2020 · English · DOAJ

    Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disorder resulting from autoantibodies produced by B-cell derived plasma cells. Clinical presentation ranges from mild skin rash to multiorgan failure. Regardless of the clinical presentation or severity of the disease…

  17. Journal Article

    Pancytopenia Secondary to Adult Osteopetrosis

    Abdullah Y. Alkhowaiter; Anwer S. Alenazi; Ali G. Alghamdi

    European Medical Journal Hematology, Vol. 8 No. 1 · 2020 · English · DOAJ

    Osteopetrosis (OP) is a rare genetically metabolic bone disorder caused by severe impairment of osteoclast-mediated bone resorption. It is characterised by extensive sclerosis of the skeleton, fragility fracture, haematopoietic insufficiency, nerve entrapment syndromes, and growth impairment. It is…

  18. Journal Article

    A Review of the Different Haematological Parameters and Biomarkers Used for Diagnosis of Neonatal Sepsis

    Prachi Gandhi; Santosh Kondekar

    European Medical Journal Hematology, Vol. 7 No. 1 · 2019 · English · DOAJ

    Neonatal sepsis is a major cause of morbidity and mortality in newborns. It presents a diagnostic challenge to the neonatologists due to a lack of objective evaluation. It may mimic noninfective conditions, such as inborn error of metabolism, birth asphyxia, and even respiratory distress syndrome…

  19. Journal Article

    New Insights in β-Thalassaemia

    Etienne Paubelle; Xavier Thomas

    European Medical Journal Hematology, Vol. 7 No. 1 · 2019 · English · DOAJ

    Thalassaemia is a hereditary cause of hypochromic microcytic anaemia resulting from defects in haemoglobin production. β-thalassaemia, which is caused by a decrease in the production of β-globin chains, affects multiple organs and is associated with considerable morbidity and mortality. This review…